Sermo company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Recap | Alive

Total Raised


Mosaic Score

+40 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Sermo

Sermo offers an online community for physicians to exchange observations and knowledge. Physicians use the company's website to aggregate observations from their daily practice and then challenge or corroborate each others' opinions, accelerating the emergence of trends and new insights on medications, devices, and treatments.

Sermo Headquarter Location

200 Park Avenue South Suite 1301

New York, New York, 10003,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Sermo

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sermo is included in 2 Expert Collections, including Pharma Supply Chain.


Pharma Supply Chain

1,258 items


Digital Health

12,800 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Sermo Patents

Sermo has filed 9 patents.

The 3 most popular patent topics include:

  • Human proteins
  • Internet culture
  • Online chat
patents chart

Application Date

Grant Date


Related Topics




Financial markets, Social networking services, Derivatives (finance), Network theory, Social information processing


Application Date


Grant Date



Related Topics

Financial markets, Social networking services, Derivatives (finance), Network theory, Social information processing



Latest Sermo News

Sermo Survey Reveals New Lung & Breast Cancer Research Rated as Most Interesting by Oncologists Attending ASCO This Year

May 19, 2022

Sermo Survey Reveals New Lung & Breast Cancer Research Rated as Most Interesting by Oncologists Attending ASCO This Year Oncologists Also Report Fewer Preventative Cancer Screenings Taking Place in Their Practices, Raising Fears of Undetected Cancers in Patients News provided by SERMO NEW YORK--( Business Wire / Korea Newswire ) May 19, 2022 -- A new survey from Sermo, a physician-first online community and leader in global HCP insights, timed to the annual American Society of Clinical Oncology (ASCO) conference found that nearly half (47%) of attending oncologists are most interested in new data being presented about lung cancer. This is followed by a similarly high interest in new data about breast cancer, as reported by 44% of oncologists surveyed. Additionally, oncologists/hematologists reported they are most excited about learning about tumor targeting antibodies treatments as reported by 54% of those surveyed. Ahead of ASCO’s Annual Meeting, new cancer research and innovations are the driving reason surveyed oncologists/hematologists are attending the conference this year (59%). However, how they plan to attend looks different to many oncologists, as only 18% of oncologists/hematologists surveyed said they will attend ASCO in-person this year. A Look Into the Pandemic’s Negative Impacts on Cancer Care Globally Oncologists are concerned about how the pandemic has affected current and potential future cancer patients. More than three-fourths (76%) of oncologists/hematologists surveyed said they had seen patients in their practice delay appointments and treatment due to the pandemic. Also worrying many oncologists/hematologists, more than half (52%) of those surveyed said their practice has seen a decreased rate of cancer screenings. Most commonly they reported seeing a decrease in mammogram screens (74%) and colonoscopy (70%). “I survived my own cancer battle at the height of Covid after finding out I had acute myeloid leukemia from a screening, so this topic is near and dear to my heart,” said Peter Kirk, Sermo CEO. “This survey reveals we still have a long ways to go to get back to “normal” in terms of prevention and cancer care, and events like ASCO are critical in reinforcing the highest treatment standards and new innovations in the fight to end cancer globally.” Other concerns oncologists had about how the pandemic has affected patients in their practice include: · Half of the oncologists/hematologists surveyed (51%) said that cancer patients in their practice felt “left behind” as cities rushed to return to normal · Long Covid is a significant issue for cancer patients who have been previously infected. Two-thirds (66%) of oncologists/hematologists surveyed said that cancer patients they are treating in their practice who have been previously infected are dealing with Long Covid issues. · The majority of oncologists/hematologists (89%) surveyed are recommending a second booster to those patients in their practice who qualify. This survey was fielded as part of Sermo’s ongoing Real Time Barometer as a special edition timed to the annual ASCO conference. The survey included more than 300 oncologists and oncologists/hematologists in the US and EU5 between April 27th- May 6th, 2022. To explore more findings from Sermo’s latest Real Time Barometer, visit About Sermo: Sermo turns physician experience, expertise, and observations into actionable insights for the global healthcare community. Engaging with more than 1.3 million HCPs across 150 countries, the company provides physicians with a social platform and unique community that fosters impactful peer-to-peer collaboration & discussions about issues that are important to them and their patients. Sermo offers on-demand access to physicians via a suite of proprietary technology to provide business intelligence that benefits pharmaceutical, healthcare partners, and the medical community at large. To learn more, visit View source version on

Sermo Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Sermo Rank

  • When was Sermo founded?

    Sermo was founded in 2000.

  • Where is Sermo's headquarters?

    Sermo's headquarters is located at 200 Park Avenue South, New York.

  • What is Sermo's latest funding round?

    Sermo's latest funding round is Recap.

  • How much did Sermo raise?

    Sermo raised a total of $42.7M.

  • Who are Sermo's competitors?

    Competitors of Sermo include Doximity and 4 more.

You May Also Like


iMedExchange is connecting physicians around the country. Every doctor can benefit from the enormous potential resource that exists in other physicians. iMedExchange is empowering doctors to connect with their colleagues in an efficient, fun, and easy way. But the company also give doctors something to talk about. Like the latest news on the hottest ultrasound device, tools to better run a practice, even what wine to have with dinner Saturday night. Along with social networking, iMedExchange offers value-added resources for the clinical, business and personal sides of a doctor's life.


UpHill is making healthcare safer by delivering training and performance analysis software.


MedShr is an easy and safe way for medical professionals to discover, discuss and share clinical cases and medical images.

H1 Logo

H1 provides a platform that contains authoritative information about every Healthcare Provider (HCP) worldwide, including academics, clinicians, and allied health professionals. The platform connects stakeholders across the healthcare ecosystem for greater partnership, collaboration and discovery.

Doctolib Logo

Doctolib offers a mobile and online platform to make reservations with doctors.

Airstrip Technologies

AirStrip seeks to make improvements in worldwide healthcare delivery by creating technology for caregivers to collaborate and care for their patients. AirStrip provides a complete, vendor and data source-agnostic, enterprise-wide mobile interoperability platform that advances care collaboration.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.